Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Zinc phthalocyanines attached to gold nanorods for simultaneous hyperthermic and photodynamic therapies against melanoma in vitro — Lucas Freitas de Freitas (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Zinc phthalocyanines attached to gold nanorods for simultaneous hyperthermic and photodynamic therapies against melanoma in vitro
Shared by
Michael R Hamblin
Zinc phthalocyanines attached to gold nanorods for simultaneous hyperthermic and photodynamic therapies against melanoma in vitro
Article
2017
en
Authors
+4 more
LF
Lucas Freitas de Freitas
Michael R Hamblin
FA
Florian Anzengruber
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2015
Gold nanorods with attached phthalocyanines for PDT and hyperthermia on melanoma cells
Lucas Freitas de Freitas
,
Florian Anzengruber
,
Ana Maria de Guzzi Plepis
,
Michael R Hamblin
Article
2013
Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies
Beike Wang
,
Jiahong Wang
,
Qian Liu
,
Hao Huang
,
Ming Chen
,
Kaiyang Li
,
Chengzhang Li
,
Xue‐Feng Yu
,
Paul Kim Ho Chu
Article
2012
Sensitive and simultaneous detection of different disease markers using multiplexed gold nanorods
Haowen Huang
,
Fang Liu
,
Shaowen Huang
,
Shishan Yuan
,
Bo Liao
,
Shoujun Yi
,
Yunlong Zeng
,
Paul Kim Ho Chu
Article
2014
Electrochemistry and Electrocatalysis at Single Gold Nanoparticles Attached to Carbon Nanoelectrodes
Yun Yu
,
Yang Gao
,
Keke Hu
,
Pierre‐Yves Blanchard
,
Jean‐Marc Noël
,
K.L.N. Phani
,
Gary Friedman
,
Yury Gogotsi
,
Michael V. Mirkin
Preprint
2020
Pillar[5]arene-Modified Gold Nanorods as Nanocarriers for Multi-Modal Imaging-Guided Synergistic Photodynamic-Photothermal Therapy
Nan Song
,
Zhijun Zhang
,
Peiying Liu
,
Dihua Dai
,
Chao Chen
,
Youmei Li
,
Lei Wang
,
Ting Han
,
Ying‐Wei Yang
,
Dong Wang
,
Ben Zhong Tang
Discussion(0)
No comments yet. Be the first to comment.